These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 22868903)

  • 21. Concordance of P450 2D6 (debrisoquine hydroxylase) phenotype and genotype: inability of dextromethorphan metabolic ratio to discriminate reliably heterozygous and homozygous extensive metabolizers.
    Evans WE; Relling MV
    Pharmacogenetics; 1991 Dec; 1(3):143-8. PubMed ID: 1688245
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Substrate specific metabolism by polymorphic cytochrome P450 2D6 alleles.
    Bogni A; Monshouwer M; Moscone A; Hidestrand M; Ingelman-Sundberg M; Hartung T; Coecke S
    Toxicol In Vitro; 2005 Aug; 19(5):621-9. PubMed ID: 15893449
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Information theory-based analysis of CYP2C19, CYP2D6 and CYP3A5 splicing mutations.
    Rogan PK; Svojanovsky S; Leeder JS
    Pharmacogenetics; 2003 Apr; 13(4):207-18. PubMed ID: 12668917
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic polymorphism of debrisoquine oxidation: restriction fragment analysis and allele-specific amplification of mutant alleles of CYP2D6.
    Heim MH; Meyer UA
    Methods Enzymol; 1991; 206():173-83. PubMed ID: 1686063
    [No Abstract]   [Full Text] [Related]  

  • 25. Complexities of CYP2D6 gene analysis and interpretation.
    Gaedigk A
    Int Rev Psychiatry; 2013 Oct; 25(5):534-53. PubMed ID: 24151800
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sequencing the CYP2D6 gene: from variant allele discovery to clinical pharmacogenetic testing.
    Yang Y; Botton MR; Scott ER; Scott SA
    Pharmacogenomics; 2017 May; 18(7):673-685. PubMed ID: 28470112
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Pharmacogene Variation (PharmVar) Consortium: Incorporation of the Human Cytochrome P450 (CYP) Allele Nomenclature Database.
    Gaedigk A; Ingelman-Sundberg M; Miller NA; Leeder JS; Whirl-Carrillo M; Klein TE;
    Clin Pharmacol Ther; 2018 Mar; 103(3):399-401. PubMed ID: 29134625
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impaired expression of CYP2D6 in intermediate metabolizers carrying the *41 allele caused by the intronic SNP 2988G>A: evidence for modulation of splicing events.
    Toscano C; Klein K; Blievernicht J; Schaeffeler E; Saussele T; Raimundo S; Eichelbaum M; Schwab M; Zanger UM
    Pharmacogenet Genomics; 2006 Oct; 16(10):755-66. PubMed ID: 17001295
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The human debrisoquine 4-hydroxylase (CYP2D) locus: sequence and identification of the polymorphic CYP2D6 gene, a related gene, and a pseudogene.
    Kimura S; Umeno M; Skoda RC; Meyer UA; Gonzalez FJ
    Am J Hum Genet; 1989 Dec; 45(6):889-904. PubMed ID: 2574001
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression, purification, biochemical characterization, and comparative function of human cytochrome P450 2D6.1, 2D6.2, 2D6.10, and 2D6.17 allelic isoforms.
    Yu A; Kneller BM; Rettie AE; Haining RL
    J Pharmacol Exp Ther; 2002 Dec; 303(3):1291-300. PubMed ID: 12438554
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of CYP2D6*3 and 2D6*4 allelic variants by PCR-restriction fragment length polymorphism.
    Topić E; Stefanović M; Nikolić V; Zoricić I; Ivanisević AM; Zuntar I
    Clin Chem Lab Med; 1998 Aug; 36(8):655-8. PubMed ID: 9806480
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DNA microarray technology in the clinical environment: the AmpliChip CYP450 test for CYP2D6 and CYP2C19 genotyping.
    de Leon J; Susce MT; Johnson M; Hardin M; Maw L; Shao A; Allen AC; Chiafari FA; Hillman G; Nikoloff DM
    CNS Spectr; 2009 Jan; 14(1):19-34. PubMed ID: 19169185
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genotypes for the cytochrome P450 enzymes CYP2D6 and CYP2C19 in human longevitY. Role of CYP2D6 and CYP2C19 in longevity.
    Bathum L; Andersen-Ranberg K; Boldsen J; Brøsen K; Jeune B
    Eur J Clin Pharmacol; 1998 Jul; 54(5):427-30. PubMed ID: 9754988
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic polymorphisms of CYP2D6 in Chinese mainland.
    Ji L; Pan S; Wu J; Marti-Jaun J; Hersberger M
    Chin Med J (Engl); 2002 Dec; 115(12):1780-4. PubMed ID: 12622923
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of the CYP2D6 and CYP2C19 genotypes on venlafaxine pharmacokinetics in a Japanese population.
    Fukuda T; Nishida Y; Zhou Q; Yamamoto I; Kondo S; Azuma J
    Eur J Clin Pharmacol; 2000 May; 56(2):175-80. PubMed ID: 10877013
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A genetic bias in clinical trials? Cytochrome P450-2D6 (CYP2D6) genotype in general vs selected healthy subject populations.
    Chen S; Kumar S; Chou WH; Barrett JS; Wedlund PJ
    Br J Clin Pharmacol; 1997 Sep; 44(3):303-4. PubMed ID: 9296329
    [No Abstract]   [Full Text] [Related]  

  • 37. CYP2D6, SULT1A1 and UGT2B17 copy number variation: quantitative detection by multiplex PCR.
    Gaedigk A; Twist GP; Leeder JS
    Pharmacogenomics; 2012 Jan; 13(1):91-111. PubMed ID: 22111604
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of CYP2C19 and CYP2D6 genotypes on the metabolism of clomipramine in Japanese psychiatric patients.
    Yokono A; Morita S; Someya T; Hirokane G; Okawa M; Shimoda K
    J Clin Psychopharmacol; 2001 Dec; 21(6):549-55. PubMed ID: 11763000
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Flexible and Scalable Full-Length CYP2D6 Long Amplicon PacBio Sequencing.
    Buermans HP; Vossen RH; Anvar SY; Allard WG; Guchelaar HJ; White SJ; den Dunnen JT; Swen JJ; van der Straaten T
    Hum Mutat; 2017 Mar; 38(3):310-316. PubMed ID: 28044414
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional characterization of 50 CYP2D6 allelic variants by assessing primaquine 5-hydroxylation.
    Saito T; Gutiérrez Rico EM; Kikuchi A; Kaneko A; Kumondai M; Akai F; Saigusa D; Oda A; Hirasawa N; Hiratsuka M
    Drug Metab Pharmacokinet; 2018 Dec; 33(6):250-257. PubMed ID: 30366777
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.